Form EFFECT Hepion Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 15, 2024 4:30 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bildad St. Louis Expands Digital Healthcare Platform With Clinical Care, Peer Support, and Concierge Navigation
- Why Commercial Permitting Delays Start Before You File a Single Document
- 49th Parallel Wealth Management Launches Cross-Border Day Tracker App to Help Snowbirds and Dual Residents Avoid Unintended U.S. Tax Residency
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
